[Form 3] XBiotech Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Form 3 filed for XBiotech Inc. (XBIT) by Troy Tevi David, indicating his status as a director of the issuer. The filing states the date of the event requiring the statement as 08/29/2025 and discloses that no securities are beneficially owned by the reporting person at the time of filing. The form is signed and dated 09/29/2025.

Positive

• Form 3 was filed, meeting SEC initial disclosure requirements for insider reporting
• Identifies the reporting person as a director, providing clarity on the individual's role

Negative

• No securities are beneficially owned by the reporting person, so there is no disclosed insider equity alignment with shareholders

Insights

Corporate Governance Expert

TL;DR: Director appointment recorded; disclosure shows no current equity stake.

The filing documents Troy Tevi David as a director of XBiotech Inc. and fulfills Section 16 initial reporting obligations by submitting a Form 3. Notably, the report states no beneficial ownership of issuer securities at filing, which can be relevant for governance transparency and insider trading monitoring. This is a routine disclosure with limited immediate financial impact.

Securities Compliance Analyst

TL;DR: Compliance filing completed; absence of owned securities reduces immediate disclosure of insider holdings.

The reporter timely completed an initial beneficial-ownership statement for XBIT, indicating the triggering event date of 08/29/2025. The explicit statement that no securities are beneficially owned means there are no Section 16 ownership positions to monitor for short-swing profit rules at this time. This is procedural and unlikely to be material to valuation.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Troy Tevi David

(Last) (First) (Middle)

11816 KEMP MILL ROAD

(Street)

SILVER SPRING MD 20902

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/29/2025

3. Issuer Name and Ticker or Trading Symbol
XBiotech Inc. [ XBIT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Tevi Troy	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the XBIT Form 3 filed by Troy Tevi David disclose?

The Form 3 discloses that Troy Tevi David is a director of XBiotech Inc. and that he does not beneficially own any securities of the issuer as of the filing.

When was the event requiring the Form 3 for XBiotech (XBIT)?

The date of the event requiring the statement is listed as 08/29/2025.

When was the Form 3 signed for XBiotech (XBIT)?

The Form 3 bears the signature date of the reporting person as 09/29/2025.

Does this Form 3 report any derivative or non-derivative holdings for XBIT?

No. The filing explicitly states no securities are beneficially owned, and no derivative or non-derivative holdings are listed.

Is this Form 3 filing material for investors in XBiotech (XBIT)?

This is primarily a routine disclosure establishing the director's status and current lack of ownership; the filing itself is generally considered non-material to company valuation absent other context.